Hostname: page-component-89b8bd64d-j4x9h Total loading time: 0 Render date: 2026-05-07T19:29:32.381Z Has data issue: false hasContentIssue false

Multiattribute judgment: Acceptance of a new COVID-19 vaccine as afunction of price, risk, and effectiveness

Published online by Cambridge University Press:  01 January 2023

Michael H. Birnbaum*
Affiliation:
Department of Psychology, California State University, Fullerton
Rights & Permissions [Opens in a new window]

Abstract

This paper illustrates how to apply the RECIPE design to evaluate multiattributejudgment, reporting an experiment in which participants judged intentions toreceive a new vaccine against COVID-19. The attributes varied were Price of thevaccine, Risks of side effects as reported in trials, and Effectiveness of thevaccine in preventing COVID. The RECIPE design is a union of factorial designsin which each of three attributes is presented alone, in pairs with each of theother attributes, and in a complete factorial with all other information.Consistent with previous research with analogous judgment tasks, the additiveand relative weight averaging models with constant weights could be rejected infavor of a configural weight averaging model in which the lowest-valuedattribute receives additional weight. That is, people are unlikely to acceptvaccination if Price is too high, Risk is too high, or Effectiveness is too low.The attribute with the greatest weight was Effectiveness, followed by Risk ofside-effects, and Price carried the least weight.

Information

Type
Research Article
Creative Commons
Creative Common License - CCCreative Common License - BY
The authors license this article under the terms of the Creative Commons Attribution 3.0 License.
Copyright
Copyright © The Authors [2021] This is an Open Access article, distributed under the terms of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Figure 0

Figure 1: Example of display of one trial.

Figure 1

Table 1: Parameter estimates of configural-weight averaging model.

Figure 2

Figure 2: Mean judgments of intention to take the new vaccine in the AB design (Price by Risk), as a function of the estimated scale value of Risk (B), with separate markers and curve for each level of Price (A). A1, A2, and A3 refer to Price = $10,000, $400, and $20; the lines show the predictions of configural weight model, labeled P_A1, P_A2, and P_A3, respectively.

Figure 3

Figure 3: Mean judgments in the AC (Price by Effectiveness) design, plotted as a function of estimated scale values of C (Effectiveness), with a separate curve for each level of A (Price); markers show mean judgments and lines show best-fit predictions of the model.

Figure 4

Figure 4: Mean judgments in the BC design, plotted as a function of estimated scale values of C (Effectiveness), with separate markers and curve for each level of B (Risk); markers show mean judgments and lines show best-fit predictions of the model.

Figure 5

Figure 5: Mean judgments of intention to take the new vaccine in the ABC sub-design (Price by Risk by Effectiveness), plotted as a function of the estimated scale value of C (Effectiveness), with a separate curve for each level of B (Risk), where A = 1 (Price = $10,000).

Figure 6

Figure 6: Mean judgments in the ABC sub-design (Price by Risk by Effectiveness), as a function of the estimated scale value of Effectiveness, with a separate curve for each level of Risk, where A = 2 (Price = $400).

Figure 7

Figure 7: Mean judgments in the ABC sub-design (Price by Risk by Effectiveness), as a function of scale values of Effectiveness, with a separate curve for each level of Risk, where Price = $20.

Figure 8

Figure 8: Effects of A (Price): Marginal mean judgments as a function of the estimated scale value of Price, with separate markers (data) and curve (predictions) for each sub-design in which A appears.

Figure 9

Figure 9: Effects of B (Risk): Marginal mean judgments as a function of the estimated scale value of Risk, with separate markers (data) and curve (predictions) for each sub-design including B.

Figure 10

Figure 10: Effects of C (Effectiveness): Marginal mean judgments as a function of the estimated scale value of Effectiveness, with separate markers and curve for each sub-design in which C appears.

Figure 11

Table 2: Analogies among studies of judgment showing divergent interactions.

Supplementary material: File

Birnbaum supplementary material

Birnbaum supplementary material
Download Birnbaum supplementary material(File)
File 211.8 KB